Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rho-kinase: a potential link between hypercholesterolemia and abnormal vascular smooth muscle contraction.

Literature DB >> 16888249

Rho-kinase: a potential link between hypercholesterolemia and abnormal vascular smooth muscle contraction.

James K Liao.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16888249 PMCID： PMC2662040 DOI： 10.1161/01.RES.0000236798.01988.5d

Source DB: PubMed Journal: Circ Res ISSN： 0009-7330 Impact factor: 17.367

× No keyword cloud information.

26 in total

1. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho.

Authors: T Matsui; M Amano; T Yamamoto; K Chihara; M Nakafuku; M Ito; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal: EMBO J Date: 1996-05-01 Impact factor: 11.598

2. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.

Authors: T Leung; X Q Chen; E Manser; L Lim
Journal: Mol Cell Biol Date: 1996-10 Impact factor: 4.272

3. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors: O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal: FEBS Lett Date: 1996-08-26 Impact factor: 4.124

4. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.

Authors: M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya
Journal: Nature Date: 1997-10-30 Impact factor: 49.962

5. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase).

Authors: M Amano; M Ito; K Kimura; Y Fukata; K Chihara; T Nakano; Y Matsuura; K Kaibuchi
Journal: J Biol Chem Date: 1996-08-23 Impact factor: 5.157

6. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans.

Authors: O Tamai; H Matsuoka; H Itabe; Y Wada; K Kohno; T Imaizumi
Journal: Circulation Date: 1997-01-07 Impact factor: 29.690

7. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors: K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal: Science Date: 1996-07-12 Impact factor: 47.728

8. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

Authors: T J Anderson; I T Meredith; A C Yeung; B Frei; A P Selwyn; P Ganz
Journal: N Engl J Med Date: 1995-02-23 Impact factor: 91.245

9. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

Authors: C B Treasure; J L Klein; W S Weintraub; J D Talley; M E Stillabower; A S Kosinski; J Zhang; S J Boccuzzi; J C Cedarholm; R W Alexander
Journal: N Engl J Med Date: 1995-02-23 Impact factor: 91.245

10. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes.

Authors: T Leung; E Manser; L Tan; L Lim
Journal: J Biol Chem Date: 1995-12-08 Impact factor: 5.157

4 in total

4. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.

Authors: Ron Rawlings; Anju Nohria; Ping-Yen Liu; Jason Donnelly; Mark A Creager; Peter Ganz; Andrew Selwyn; James K Liao
Journal: Am J Cardiol Date: 2008-12-25 Impact factor: 2.778